US 12414943
Nimodipine parenteral administration
granted A61KA61K31/4422A61K47/10
Quick answer
US patent 12414943 (Nimodipine parenteral administration) held by Grace Therapeutics U.S., Inc. expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Grace Therapeutics U.S., Inc.
- Grant date
- Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/4422, A61K47/10, A61K47/24, A61K47/26